PIPERACILLIN 1GM & TAZOBACTUM 125MG Injection

Piperacillin 1g + Tazobactam 125mg Injection
Broad-Spectrum Power with β-Lactamase Inhibition

Piperacillin 1g + Tazobactam 125mg Injection is a synergistic combination of an extended-spectrum penicillin antibiotic (Piperacillin) and a potent β-lactamase inhibitor (Tazobactam) that delivers broad and reliable antibacterial coverage, including against β-lactamase-producing resistant organisms. This formulation is ideal for managing moderate to severe infections in hospital and critical care settings.

Key Benefits:

• Expanded Spectrum of Activity
  Effectively targets a wide range of Gram-positive, Gram-negative, and anaerobic bacteria—including Pseudomonas aeruginosa.

• Enhanced Efficacy Against Resistant Pathogens
  Tazobactam inhibits β-lactamase enzymes, preserving Piperacillin’s effectiveness against resistant strains.

• Ideal for Hospital-Acquired Infections
  A trusted solution for treating polymicrobial and nosocomial infections, including ICU-related conditions.

• Flexible IV Use
  Administered intravenously, ensuring rapid and reliable tissue distribution and therapeutic levels.

Indications:

• Lower respiratory tract infections (e.g., pneumonia)

• Intra-abdominal infections

• Urinary tract infections

• Skin and soft tissue infections

• Gynecological infections

• Septicemia and bacteremia

• Post-surgical infections

Dosage & Administration:
Administered via intravenous infusion. Dose and duration depend on infection severity, renal function, and patient weight.

Important Safety Information:
Use with caution in patients with a history of penicillin allergies. Monitor renal and hepatic function during prolonged therapy. Common side effects include GI disturbances, rash, and electrolyte imbalance.